NSRX
Nasus Pharma·AMEX
--
--(--)
--
--(--)
5.04 / 10
Netural
Fund flow metrics score 7.32/10, indicating robust capital movement despite negative trends in block, small, medium, large, and extra-large flows. Analyst coverage is limited to one source with a unanimous Buy rating, but historical performance data is sparse, contributing to a netural sentiment overall.
Fund Flow Rating
Analyst RatingBuy
Wall Street Opinions
Buy
Strong Buy
0%
Buy
100%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-12-18
InstitutionCitizens
Times predicted1
Historical Win Rate100.0%
What is the analyst consensus for NSRX?
- NSRX holds a Bearish analyst rating, with 100% of experts assigning a Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 5.04/10 (Netural).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
